Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Graphene Leaders Canada is a private Canadian nanotechnology and advanced materials company based in Edmonton, Alberta. The company develops and commercializes graphene oxide, reduced graphene oxide, pristine graphene, and graphene-enhanced application solutions across environmental, coatings, industrial, and selected healthcare markets. Its business appears to center on a graphene materials platform that is used in water treatment, corrosion-resistant and performance coatings, and a medical diagnostics subsidiary developing rapid biosensor-based pathogen detection. In healthcare, the company highlights GLC Medical's portable electrochemical impedance spectroscopy biosensor platform designed to detect viruses and other pathogens in under one minute. Overall, Graphene Leaders Canada is better characterized as a graphene platform and applications company with a healthcare/diagnostics adjacency rather than a pure-play biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Graphene Leaders Canada.